ECigIntelligence

Regulatory and market intelligence for the e-cigarette sector

Business briefing

Relx aims to raise $1bn in US stock sale amid concerns over regulation and tariffs

Written by || 21st January 2021 || Business briefing | Companies | Major brands | Asia China North America United States

China’s leading e-cigarette company, Relx, is hoping to raise up to $1.17bn from a US initial public offering (IPO) on the New York Stock Exchange ...

Restricted content. Do you want to read more?

Read our latest free content

Reporting disorder: don’t let the facts get in the way of a good bad-news story
BAT urges Middle Eastern governments to adopt tobacco harm reduction
‘Significant progress’ – but the US FDA’s biggest decisions are still to come
Vape retailers required to post age-limit signs as New Zealand takes another step
On California’s Animal Farm for former hippies it’s cannabis good, e-cigs bad
Into the great unknown as US FDA’s deadline to decide on PMTAs arrives

Featured news

Australian consumers will be able to obtain medically licensed nicotine-containing e-cigarettes from community and online pharmacies

There is still some mystery around how the new system will be implemented. How will Australia’s new sales regime work?

International | Regulation & legislation | Blog 

Sign up to our newsletter

By signing up you agree to our Terms and Conditions